STEVENSON, Md., Dec. 03, 2015 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Florida on behalf of purchasers of ERBA Diagnostics, Inc. (NYSE MKT:ERB) (“ERBA” or the “Company”) securities during the period between April 14, 2014 and November 23, 2015, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until February 1, 2016 to seek appointment as lead plaintiff.
If you have suffered a loss from investment in ERBA securities purchased on or after April 14, 2014 and held through the revelation of negative information during and/or at the end of the Class Period, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Company securities during the Class Period. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the Company lacked adequate controls over financial reporting such that its financial statements were materially false and misleading.
According to the complaint, following the Company’s November 20, 2015 disclosure that the Company’s previously issued financial statements for each of the years ended December 31, 2014 and 2013 and for each of the interim periods ended March 31, 2015 and June 30, 2015 should no longer be relied upon and that the Company intended to restate its financial statements for those periods, the value of ERBA’s shares declined significantly.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast
Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws
DOJ Grand Jury Investigates UAW President Shawn Fain Ahead of Union Election
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 



